Telmisartan
Angiotensin II receptor blocker (ARB) with unique dual activity as a partial PPAR-gamma agonist. Blocks AT1 receptors to reduce blood pressure, vascular inflammation, and aldosterone secretion. The PPAR-gamma activation provides additional insulin-sensitizing and anti-inflammatory effects not shared by other ARBs. Longest half-life in the ARB class enables true 24-hour coverage.
Three tiers ordered by aggressiveness. Tier chips on every OPTIMIZE intervention let you filter the catalog by your evidence tolerance.
- creatinine
- egfr
- lipid-panel
- fasting-glucose
- hba1c
- alt
- pregnancy
- bilateral-renal-artery-stenosis
- severe-hepatic-impairment
- hyperkalemia
- PMID:18235224Telmisartan, ramipril, or both in patients at high risk for vascular events: ONTARGET trial — N Engl J Med, 2008
- PMID:15616024Telmisartan as a metabolic modulator: PPAR-gamma activation and anti-inflammatory properties — J Hypertens, 2005
- PMID:14597593The unique metabolic profile of telmisartan among angiotensin receptor blockers — Drug Saf, 2003
Telmisartan is the ARB that does more than lower blood pressure. Every drug in this class blocks AT1 receptors. Only telmisartan activates PPAR-gamma. That dual mechanism makes it simultaneously an antihypertensive, an insulin sensitizer, and an anti-inflammatory — three therapeutic categories from one molecule. The ONTARGET trial proved it was non-inferior to ramipril for cardiovascular protection without the ACE inhibitor cough. For the optimization community, telmisartan at 40mg is the preferred ARB because you get blood pressure control plus metabolic benefits that no other compound in the class provides. The 24-hour half-life means once-daily dosing with genuine full-day coverage. No ARB matches that pharmacokinetic profile.
This is not medical advice
Discuss with a licensed clinician before starting, stopping, or changing any compound. This page documents what the research literature describes — it is not a prescription.
See Telmisartan in a protocol matched to you